These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 545764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
    Hodson ME, Wingfield HJ, Batten JC.
    Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.
    Martin AJ, Smalley CA, George RH, Healing DE, Anderson CM.
    Arch Dis Child; 1980 Aug; 55(8):604-7. PubMed ID: 7436516
    [Abstract] [Full Text] [Related]

  • 6. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
    Hazinski TA.
    J Pediatr; 1999 Jul; 135(1):130. PubMed ID: 10428654
    [No Abstract] [Full Text] [Related]

  • 7. Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.
    Med Lett Drugs Ther; 2013 Jun 24; 55(1419):51-2. PubMed ID: 23797798
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF, Mouton J.
    Acta Univ Carol Med (Praha); 1990 Jun 24; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract] [Full Text] [Related]

  • 10. Tobramycin inhalation solution (Bethkis) for cystic fibrosis.
    Med Lett Drugs Ther; 2014 Jun 23; 56(1445):51-2. PubMed ID: 24956309
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum.
    McCrae WM, Raeburn JA, Hanson EJ.
    J Infect Dis; 1976 Aug 23; 134 Suppl():S191-3. PubMed ID: 972281
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of pseudomonas infections in cystic fibrosis using tobramycin.
    McCrae WM.
    Scott Med J; 1976 Apr 23; 21(2):68-9. PubMed ID: 940997
    [No Abstract] [Full Text] [Related]

  • 15. Antibiotic treatment of cystic fibrosis.
    Jedlicková Z, Vávrová V, Houstĕk J, Výmola F.
    Acta Univ Carol Med (Praha); 1990 Apr 23; 36(1-4):42-3. PubMed ID: 2130716
    [No Abstract] [Full Text] [Related]

  • 16. A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis.
    Valletta EA, Rigo A, Bonazzi L, Zanolla L, Mastella G.
    Acta Univ Carol Med (Praha); 1990 Apr 23; 36(1-4):44-5. PubMed ID: 2130717
    [Abstract] [Full Text] [Related]

  • 17. Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis.
    Adeboyeku D, Scott S, Hodson ME.
    J Cyst Fibros; 2006 Dec 23; 5(4):261-3. PubMed ID: 16807142
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
    Geller DE, Konstan MW, Smith J, Noonberg SB, Conrad C.
    Pediatr Pulmonol; 2007 Apr 23; 42(4):307-13. PubMed ID: 17352404
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.